Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $93 Price Target
Portfolio Pulse from richadhand@benzinga.com
Rosenblatt analyst Steve Frankel has reiterated a 'Buy' rating on Dolby Laboratories (NYSE:DLB) and maintained a price target of $93.
July 28, 2023 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Dolby Laboratories' stock rating has been reiterated as 'Buy' by Rosenblatt analyst Steve Frankel, with a maintained price target of $93.
The reiteration of a 'Buy' rating by a reputable analyst like Steve Frankel indicates a positive outlook for Dolby Laboratories. The maintained price target of $93 suggests that the analyst believes the stock is undervalued at current prices, which could lead to upward pressure on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100